2016 25 June (6) 2
Molecular Imaging and Radionuclide Therapy Indexed in Emerging Sources Citation Index (ESCI).
Pubmed Central


Use of Positron Emission Tomography/Computed Tomography in Radiation Treatment Planning for Lung Cancer

(Mol Imaging Radionucl Ther 2016; 25: 50-62)

Original Article

Morphologic and Metabolic Comparison of Treatment Responsiveness with 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography According to Lung Cancer Type

(Mol Imaging Radionucl Ther 2016; 25: 63-69)

Evaluation of Silent Myocardial Ischemia with Single-Photon Emission Computed Tomography/Computed Tomography in Asymptomatic Subjects with Diabetes and Pre-Diabetes

(Mol Imaging Radionucl Ther 2016; 25: 70-78)

Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success?

(Mol Imaging Radionucl Ther 2016; 25: 79-84)

Recurrence Incidence in Differentiated Thyroid Cancers and the Importance of Diagnostic Iodine-131 Scintigraphy in Clinical Follow-up

(Mol Imaging Radionucl Ther 2016; 25: 85-90)

Case Report

Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation?

(Mol Imaging Radionucl Ther 2016; 25: 91-96)

Sentinel Lymph Node Detection by 3D Freehand Single-Photon Emission Computed Tomography in Early Stage Breast Cancer

(Mol Imaging Radionucl Ther 2016; 25: 97-101)

Kikuchi Disease with Generalized Lymph Node, Spleen and Subcutaneous Involvement Detected by Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

(Mol Imaging Radionucl Ther 2016; 25: 102-106)
Home Archive Search Menu